Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

Published:2004-07 Issue:9431 Volume:364 Page:347-354
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Anand Inder,McMurray John,Cohn Jay N,Konstam Marvin A,Notter Thomas,Quitzau Kurt,Ruschitzka Frank,Lüscher Thomas F

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells;Yanagisawa;Nature,1988

2. Contribution of endogenous generation of endothelin-1 to basal vascular tone;Haynes;Lancet,1994

3. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels;Seo;Circulation,1994

4. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade;Yang;Circulation,1999

5. Endothelium-dependent modulation of responses to endothelin-1 in human veins;Haynes;Clin Sci,1993

Cited by 309 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is endothelin targeting finally ready for prime time?;Clinical Science;2024-05-24

2. Pulmonary Hypertension Related to Left Heart Disease (PH-LHD);Current Respiratory Medicine Reviews;2024-05

3. Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure;Heart Failure Clinics;2024-04

4. Current and future strategies for targeting the endothelin pathway in cardiovascular disease;Nature Cardiovascular Research;2023-11-02

5. Endothelin-1;JACC: CardioOncology;2023-10